菜单
JP Medical Consulting Pty Ltd (ACN 673 260 056, JP Medical) is pleased to announce the appointment of Mr. Neil Finlayson as Chief Operating Officer (COO). Mr. Neil Finlayson brings with him over 30 years of extensive experience in drug development, clinical development, project management, and commercialization. He has served as CEO of several vaccine…
阅读文章
JP Medical Consulting Pty Ltd (ACN 673 260 056, JP Medical) is pleased to announce the appointment of Ms. Nicoletta Muner as Senior Vice President, Global Regulatory Affairs. Ms. Nicoletta Muner brings over 25 years of experience in the pharmaceutical industry, covering product development, preclinical and clinical development, and international regulatory affairs. She is the…
阅读文章
On the afternoon of 13 November 2025, the Department of Obstetrics and Gynecology at the Second Affiliated Hospital of Chongqing Medical University successfully hosted Professor Mark von Itzstein, an internationally renowned glycomics expert and Fellow of both the Royal Australian Chemical Institute and the Australian Academy of Science, together with Professor Jianhong Pang, founder of…
阅读文章
Recently, Boji Medical Technology Co., Ltd. (hereinafter referred to as “Boji Medical”) and JP Medical Consulting Pty Ltd of Australia (hereinafter referred to as “JP Medical Consulting”) officially announced the establishment of a strategic partnership. This collaboration will integrate the clinical resources and professional strengths of both parties in the China–Australia pharmaceutical field, provide Chinese…
阅读文章
Queensland has long been an ideal destination for early-phase clinical trials. On May 20, the Shanghai–Queensland Biopharmaceutical Industry Development Seminar was successfully held at the Medical Device Innovation Center in the Lin-gang Special Area of Shanghai. The event brought together dozens of professionals from the biomedicine sector. Discussions focused on key topics such as Queensland’s…
阅读文章
On May 20, Xiying (Shanghai) Medical Technology Co., Ltd. (hereinafter referred to as “Xiying Medical”) and JP Medical Consulting Pty Ltd. of Australia (hereinafter referred to as “JP Medical Consulting”) officially signed a strategic cooperation agreement at the National Innovation Park of East China University of Science and Technology in Shanghai. The two parties will…
阅读文章
The Australia Pavilion at the 2025 DIA China Annual Meeting is hosted by the Commercial Section of the Australian Embassy and Consulates in China, together with the Australian Trade and Investment Commission (Austrade). It serves as a key platform to showcase Australia’s strengths in clinical trials and biotechnology. We invite you to visit Booth L16…
阅读文章